Loading clinical trials...
Loading clinical trials...
The project is targeting cognitive impairment, one of the main health problems of patients with RAS pathway disorders. The aim of this study is to translate findings of animal studies to humans. This ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Technical University of Munich
NCT02290834 · Impaired Cognition, Chemo-brain, and more
NCT02551952 · Cognition Disorders, Impaired Cognition, and more
NCT01739933 · Sepsis, Delirium, and more
NCT04557592 · Gait Apraxia, Alzheimer Disease, and more
NCT02936401 · Impaired Cognition, HIV Infection
Technical University Munich
Munich
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions